Finally: How to Treat COVID Infection at the Source

Probably the broadest, most practical advancement that has come from our response to the pandemic is not a drug or vaccine from Operation Warp Speed, rather it’s an understanding the SARS-CoV-2 like all upper respiratory tract viral infections starts in the nasopharynx and can be treated topically at the source.[1]

Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the prior strains of the virus. Thus, there is a wonderful opportunity to reduce viral replication, in fact, kill viruses with agents directly applied in the nasal cavity and the back of the throat.

Use of directly applied therapy is far more effective than swallowing pills or capsules or receiving an intravenous infusion. The nasal mucosa is a barrier for entry and if functioning well, allows little penetration of virions into systemic circulation where for example a monoclonal antibody could work. Thus, the McCullough Protocol© starting in 2021, featured the upfront use of nasal washes and oral gargles using viricidal agents.[2]